AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The hospital in association with ‘We Warriors’ and ‘Dev Bhumi Rakshak Foundation’ organized First Aid and CPR training session for youngsters and volunteers
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
Subscribe To Our Newsletter & Stay Updated
